COMPANY

GreenMark Biomedical Inc.

HQ: East Lansing, MI source · greenmark.bio ↗ · Midwest

Keywords: microparticles

Location: East Lansing, MI · source · Apr 14, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Filed a Form D for an offering of up to $5M, no sales reported yet (filed Apr 14, 2026). SEC Form D 0001741718-26-000003 (Apr 14, 2026)
Evidence (1 event)
- Apr 14, 2026 · SEC Form D 0001741718-26-000003
  Name of Issuer: GreenMark Biomedical Inc.; CIK: 1741718; Address: East Lansing, MI; Submission type: D; Filing date: 2026-04-14; Industry Group: Biotechnology; Date of First Sale: Yet to Occur; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 5000000; Total Amount Sold: 0; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

Aug 29, 2025 Grant Government grant — SBIR: $270,594 (annual award, as published), announced Aug 29, 2025. Agency: NIH/NIDCR. Source: government award database. source ↗
Mar 27, 2025 Grant Government grant — SBIR: $294,632 (annual award, as published), announced Mar 27, 2025. Agency: NIH/NIDCR. Source: government award database. source ↗
Jan 2, 2025 FDA FDA 510(k) clearance: CrystLCare PRO Biorestorative, Fluoride-Plus — K241568, Jan 2, 2025. Applicant at approval: GreenMark Biomedical, Inc. source ↗

Last 2 years.

Aug 29, 2025 Government grant — SBIR: $270,594 (annual award, as published), announced Aug 29, 2025. Agency: NIH/NIDCR. Source: government award database. source ↗
Mar 27, 2025 Government grant — SBIR: $294,632 (annual award, as published), announced Mar 27, 2025. Agency: NIH/NIDCR. Source: government award database. source ↗

Jan 2, 2025 FDA 510(k) clearance: CrystLCare PRO Biorestorative, Fluoride-Plus — K241568, Jan 2, 2025. Applicant at approval: GreenMark Biomedical, Inc. source ↗

Annual award amounts. Total $1.7M.

Aug 24, 2020 NIH award 5R44DE027903-03 FY2020: $705,554 awarded for that fiscal year; activity R44 (SBIR); PI BLOEMBERGEN, STEVEN; recipient as written: GREENMARK BIOMEDICAL, INC., East Lansing, MI. Bioresorbable Nanoparticles fo source ↗
Sep 16, 2019 NIH award 2R44DE027903-02 FY2019: $770,105 awarded for that fiscal year; activity R44 (SBIR); PI BLOEMBERGEN, STEVEN; recipient as written: GREENMARK BIOMEDICAL, INC., East Lansing, MI. Bioresorbable Nanoparticles fo source ↗
Mar 19, 2018 NIH award 1R43DE027903-01 FY2018: $228,883 awarded for that fiscal year; activity R43 (SBIR); PI BLOEMBERGEN, STEVEN; recipient as written: GREENMARK BIOMEDICAL, INC., East Lansing, MI. Bioresorbable Nanoparticles fo source ↗

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-12